Skip to main content
TipRanks
Go Ultimate75% OFF

Yuki Gosei Kogyo Co., Ltd. (4531) AI Stock Analysis

0 Followers
JP:4531

Yuki Gosei Kogyo Co., Ltd.

(TSE/TYO:4531)

Select Model
Rating:52Neutral
Price Target:JPY 308.00â–²(0.98% Upside)
Action:reiterated
Date:09/24/26

The overall score of 52 reflects a mixed but slightly cautious outlook. The most significant factor is the divergence in financial performance: strong cash flow and a solid balance sheet are offset by weak income statement trends. Technicals are neutral, providing no positive momentum, while valuation is fair but not compelling. The lack of positive earnings call guidance or corporate catalysts further limits upside potential.

Positive Factors
Balance-sheet stabilityA consistently stronger equity base than total debt provides financial stability and some capacity to absorb operating volatility. Moderate leverage also supports continued investment and capital allocation, although the benefit depends on maintaining profitability and controlling debt growth.
Negative Factors
2026 earnings deteriorationThe simultaneous revenue decline and sharp net-income reduction point to weakened operating performance and possible margin or cost pressure. Unless profitability recovers, this deterioration can reduce reinvestment capacity and make the earlier earnings improvement less durable.

Yuki Gosei Kogyo Co., Ltd. (4531) vs. iShares MSCI Japan ETF (EWJ)

-20%0%20%40%60%80%100%JP:4531+5.29%EWJ+6.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 6.59B
Dividend Yield
3.28%
Average Volume (3M)
43.99K
Price to Earnings (P/E)
13.8
Beta (1Y)
1.22
Revenue Growth
3.90%
EPS Growth
-31.32%
Country
Japan
Employees
296
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Yuki Gosei Kogyo Co., Ltd. Business Overview & Revenue Model

Company Description

Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals for...

Yuki Gosei Kogyo Co., Ltd. Financial Statement Overview

Summary

Financial performance is mixed. The income statement shows weakness with declining revenue and compressed margins (Score: 35). However, the balance sheet is stable with reduced leverage (Score: 55), and cash flow generation has improved markedly, turning free cash flow positive with strong operating cash flow (Score: 70). The overall picture is one of near-term earnings pressure offset by solid cash generation and a manageable capital structure.

Income Statement

35Negative

Balance Sheet

55Neutral

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue16.37B15.45B15.13B12.93B12.84B12.36B
Gross Profit2.28B2.55B3.23B3.26B3.05B2.36B
EBITDA1.17B1.62B2.23B1.93B1.62B1.24B
Net Income479.00M313.00M896.00M776.00M556.00M248.00M
Balance Sheet
Total Assets25.00B25.73B27.29B24.75B22.35B21.38B
Cash, Cash Equivalents and Short-Term Investments1.84B885.00M973.00M588.00M1.14B1.86B
Total Debt5.66B6.71B8.51B6.87B5.58B5.54B
Total Liabilities11.63B12.24B14.18B12.31B10.87B10.38B
Stockholders Equity13.37B13.49B13.11B12.43B11.48B11.00B
Cash Flow
Free Cash Flow01.72B-1.20B-1.37B-490.00M1.40B
Operating Cash Flow02.84B2.14B388.00M668.00M1.79B
Investing Cash Flow0-1.01B-3.25B-1.89B-1.24B-442.00M
Financing Cash Flow0-1.92B1.50B948.00M-158.00M-772.00M

Yuki Gosei Kogyo Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price305.00

Price Trends

50DMA351.92Negative
100DMA354.20Negative
200DMA372.19Negative

Market Momentum

MACD-12.44Positive
RSI24.87Positive
STOCH12.25Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4531, the sentiment is Negative. The current price of 305.00 is below the 20-day moving average (MA) of 335.05, below the 50-day MA of 351.92, and below the 200-day MA of 372.19, indicating a bearish trend. The MACD of -12.44 indicates Positive momentum. The RSI at 24.87 is Positive, neither overbought nor oversold. The STOCH value of 12.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4531.

Yuki Gosei Kogyo Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:4531 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4041JP:404170OutperformJPY 199.99B10.79―4.76%-0.17%21.27%
JP:4040JP:404067NeutralJPY 8.09B2.21―1.87%-0.40%215.27%
JP:4093JP:409366NeutralJPY 13.77B10.27―3.55%2.52%20.63%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
JP:4970JP:497060NeutralJPY 48.97B10.52―0.81%20.83%89.46%
JP:4531JP:453152NeutralJPY 6.66B13.77―3.28%3.90%-31.32%
JP:4366JP:436648NeutralJPY 12.29B10.27―2.16%10.12%43.23%

* Basic Materials Sector Average

Performance Comparison

0%50%100%150%200%JP:4531JP:4040JP:4041JP:4093JP:4366JP:4970Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4531 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4531Yuki Gosei Kogyo Co., Ltd.305.0027.049.73%
JP:4040NANKAI CHEMICAL COMPANY LIMITED3470.00545.1618.64%
JP:4041Nippon Soda Co., Ltd.3680.00433.1513.34%
JP:4093Toho Acetylene Co., Ltd.394.0051.9415.18%
JP:4366Daito Chemix Corporation371.00111.3942.91%
JP:4970Toyo Gosei Co., Ltd.6170.0047.970.78%

Yuki Gosei Kogyo Co., Ltd. Corporate Events

Yuki Gosei Kogyo Projects Profit Rebound Despite Interim Earnings Volatility

Oct 30, 2026

Yuki Gosei Kogyo Co., Ltd., listed on the Tokyo Stock Exchange under code 4531, operates in the chemical and pharmaceutical-related sector and reports under Japanese GAAP. The company focuses on specialty chemical products, with its performance track...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026